Several previous studies have assessed single nucleotide polymorphisms (SNPs) in the EGFR gene that is implicated in human tumors, such as breast cancer [13], lung cancer [14] and prostate cancer [15]. This evidence concerns the gene EGFR and prostate carcinoma.